360
S. Striegler et al. / Journal of Catalysis 338 (2016) 349–364
and concentration to dryness, the residue obtained was purified by
column chromatography over silica gel (cyclohexane/ethyl acetate,
5/1–3/1, v/v) yielding compound 12g as a colorless solid (1.60 g,
3.361 mmol, 53%); Rf 0.25 (SiO2, cyclohexane/ethyl acetate, 2/1,
v/v); mp: 87–89 °C; dH(CDCl3) 8.34 (d, 2.8, 1H), 8.15 (dd, 2.8, 9.3,
1H), 7.31 (d, 9.3, 1H), 5.87 (d, 3.5, 1H), 5.56 (dd, 1.4, 3.4, 1H),
5.49 (dd, 3.3, 10.5, 1H), 4.26 (dt, 1.5, 6.8, 1H), 4.13–4.02 (m, 2H),
3.90 (dd, 3.5, 10.5, 1H), 3.54 (s, 3H), 2.19 (s, 3H), 2.08 (s, 3H),
1.96 (s, 3H); dC(CDCl3) 170.1, 169.9, 157.0, 142.6, 126.2, 125.0,
123.5, 115.4, 96.5, 74.8, 69.4, 68.3, 67.7, 61.3, 59.4, 20.8, 20.6,
20.5; calcd for C19H22ClNO11 C, 47.96; H, 4.66; found: C, 48.12, H,
4.64.
4.5.10. 2-Chloro-4-nitrophenyl a-D-mannopyranoside (11a) [24,25]
Colorless solid; 0.64 g (0.192 mmol, 71%) after column chro-
matography on silica gel (ethyl acetate/methanol, 30/1–20/1, v/
v); mp 156–157 °C; Rf 0.35 (SiO2, ethyl acetate/methanol, 10/1, v/
v); dH (DMSO-d6) 8.34 (dd, 2.8, 0.8, 1H), 8.20 (ddd, 9.2, 2.8, 0.9,
1H), 7.56 (d, 8.8, 1H), 5.74 (d, 1.3, 1H), 5.24 (dd, 4.5, 0.8, 1H),
4.96 (dd, 5.6, 0.6, 1H), 4.92 (dd, 5.9, 0.6, 1H), 4.46 (dd, 6.3, 5.8,
1H), 3.90 (t, 4.5, 1H), 3.70–3.77 (m, 1H), 3.48–3.62 (m, 2H), 3.39–
3.47 (m, 1H), 3.33 (s, 3H), 3.22–3.30 (m, 1H); dC (DMSO-d6)
156.6, 141.5, 125.4, 124.2, 122.6, 116.2, 99.2, 75.9, 70.5, 69.6,
66.3, 60.8; HRMS, FTMS+ m/z calcd. for C12H14ClNNaO8 [M+Na]+:
358.0306; found 358.0304.
4.5.11. 2-Chloro-4-nitrophenyl a-D-galactopyranoside (11c)
4.5.6. General procedure for the synthesis of aryl 2,3,4,6-tetra-O-
acetyl-b-D-glycopyranosides [26]
Off-white solid, 1.50 g (4.468 mol, 31%); mp 90–115 °C; Rf 0.89
(SiO2, MeOH); dH (DMSO-d6) 8.33 (d, 2.8, 1H), 8.20 (dd, 9.2, 2.9,
1H), 7.53 (d, 9.3, 1H), 5.86 (d, 3.3, 1H), 5.16 (d, 5.5, 1H), 4.97 (d,
5.3, 1H), 4.68 (d, 3.8, 1H), 4.51 (dd, 6.1, 5.4, 1H), 3.88 (dd, 5.1,
3.4, 1H), 3.76–3.86 (m, 2H), 3.56–3.65 (m, 1H), 3.46–3.55 (m,
1H), 3.35–3.42 (m, 1H); dC (DMSO-d6) 157.6, 141.2, 125.4, 124.2,
The syntheses were achieved by phase-transfer-catalyzed gly-
cosylation of phenols with peracetylated glycopyranosyl bromide
as described by Kroger et al. and us earlier [53,54]. Typically,
15 mL of a 1 N aqueous sodium hydroxide solution was added to
a solution of the peracetylated glycosyl bromide (3.5 mmol), tetra-
122.8, 115.8, 98.5, 73.5, 69.1, 68.3, 67.4, 60.1; Calcd for C12H14
-
butylammonium
bromide
(1.45 equiv.)
and
2-chloro-4-
ClNO8: C, 42.93; H, 4.20; found: C, 42.89, H, 4.29; HRMS, ESI-
TOF+ m/z calcd. for C12H14ClNO8Na [M+Na]+: 358.0300; found
358.0291.
nitrophenol (2 equiv.) in 25 mL dichloromethane. The resulting
two phase system was vigorously stirred at 35 °C for 3 h. After
cooling to ambient temperature, the mixture was diluted with
100 mL ethyl acetate. After separation of the organic layer, the
aqueous layer was extracted two times with 50 mL ethyl acetate
each. The combined organic layers were washed with 1 N aqueous
sodium hydroxide solution, 20 mL water, 20 mL brine and dried
over anhydrous sodium sulfate. After filtration, the filtrate was
concentrated to dryness yielding a residue that was purified by
column chromatography over silica gel affording the target
compounds.
4.5.12. 2-Chloro-4-nitrophenyl b-
D
-galactopyranoside (11d)
The compound was prepared as described by us previously [26].
4.5.13. 2-Chloro-4-nitrophenyl a-D-glucopyranoside (11e)
Off-white solid; 1.20 g (3.575 mmol, 25%); mp 157–159 °C; Rf
0.66 (SiO2, MeOH); dH (DMSO-d6) 8.33 (d, 2.8, 1H), 8.21 (dd,
9.3, 2.8, 1H), 7.54 (d, 9.5, 1H), 5.83 (d, 3.5, 1H), 5.33 (d, 5.3,
1H), 5.13 (t, 5.4, 2H), 4.48 (t, 5.9, 1H), 3.70 (td, 9.2, 5.0, 1H),
3.53 (ddd, 12.0, 5.8, 2.5, 1H), 3.41–3.50 (m, 2H), 3.35–3.40 (m,
1H), 3.22 (ddd, 10.0, 8.8, 5.3, 1H); dC (DMSO-d6) 157.5, 141.3,
125.5, 124.2, 122.8, 115.8, 98.2, 74.9, 72.6, 71.2, 69.4, 60.5; Calcd
for C12H14ClNO8: C, 42.93; H, 4.20; found: C, 43.05, H, 4.23;
ESI-TOF+ m/z calcd. for C12H14ClNO8Na [M+Na]+: 358.0300; found
358.0302.
4.5.7. 2-Chloro-4-nitrophenyl 2,3,4,6-tetra-O-acetyl-b-D-
glucopyranoside (12f)
Off-white solid, 4.40 g (8.733 mmol, 23%); mp 152–153 °C; Rf
0.29 (SiO2, hexane/ethyl acetate = 2/1 (v/v); dH (CDCl3) 8.32 (d,
2.6, 1H), 8.14 (dd, 9.0, 2.6, 1H), 7.24 (s, 1H), 5.12–5.46 (m, 4H),
4.30 (dd, 12.4, 5.3, 2H), 4.22 (dd, 12.4, 2.6, 2H), 3.90–3.98 (m,
2H), 2.10 (s, 3H), 2.10 (s, 3H), 2.07 (s, 3H), 2.06 (s, 3H); dC (CDCl3)
170.3, 170.0, 169.2, 168.9, 157.1, 143.0, 126.0, 124.8, 123.5, 116.3,
99.1, 72.4, 71.9, 70.3, 67.8, 61.6, 20.6, 20.5, 20.5, 20.5; calcd for
4.5.14. 2-Chloro-4-nitrophenyl b-D-glucopyranoside (11f)
Off-white solid; 1.94 (5.779 mmol, 40%); mp 181–183 °C; Rf
0.66 (SiO2, MeOH); dH (DMSO-d6) 8.15 (t, 9.0, 1H), 7.21 (dd, 13.3,
2.5, 1H), 7.04 (dd, 9.3, 2.3, 1H), 5.48 (d, 4.5, 1H), 5.18 (d, 4.5, 1H),
5.06–5.14 (m, 2H), 4.61 (t, 5.6, 1H), 3.69 (dd, 9.8, 5.3, 1H), 3.40–
3.52 (m, 2H), 3.10–3.33 (m, 3H); dC (DMSO-d6) 157.8, 141.5,
125.5, 124.3, 122.2, 115.7, 99.9, 77.3, 76.6, 73.0, 69.3, 60.5; calcd
for C12H14ClNO8, C 42.93, H 4.20; found: C 42.96, H 4.19.
C20H22ClNO12 C, 47.68; H, 4.40; found: C, 47.83, H, 4.43.
4.5.8. 2-Chloro-4-nitrophenyl 3,4,6-tri-O-acetyl-2-O-methyl-b-
D-
galactopyranoside (12h)
Purification by column chromatography over silica gel (hexane/
ethyl acetate, 3/1–1/1, v/v) as colorless solid (1.30 g, 2.731 mmol,
80%); mp 148–149 °C; Rf 0.40 (SiO2, hexane/ethyl acetate, 1/1,
v/v); dH (CDCl3) 8.34 (d, 2.5, 1H), 8.15 (dd, 2.8, 9.0, 1H), 7.20 (d,
9.3, 1H), 5.46 (dd, 0.9, 3.4, 1H), 5.10 (d, 7.5, 1H), 5.02 (dd, 3.5,
10.3, 1H), 4.26–4.02 (m, 3H), 3.76 (dd, 7.5, 10.3, 1H), 3.69 (s, 3H),
2.20 (s, 3H), 2.09 (s, 3H), 2.08 (s, 3H); dC (CDCl3); 170.2, 170.0,
157.4, 142.7, 126.2, 124.1, 123.6, 115.0, 101.1, 77.5, 72.0, 71.4,
66.9, 61.5, 61.5, 20.7, 20.7, 20.6; calcd for C19H22ClNO11 C, 47.96;
H, 4.66; found: C, 47.96, H, 4.64.
4.5.15. 2-Chloro-4-nitrophenyl 2-O-methyl-a-D-galactopyranoside
(11g)
Chromatographic purification over silica gel (hexane/ethyl acet-
ate 2/1–0/1, v/v), colorless solid; 0.81 g (2.314 mmol, 79%); mp
130–132 °C; dH (DMSO-d6) 8.33 (d, 2.8, 1H), 8.22 (dd, 2.8, 9.3,
1H), 7.55 (d, 9.3, 1H), 6.15 (d, 3.5, 1H), 5.15 (d, 6.0, 1H), 4.81 (d,
4.3, 1H), 4.52 (t, 5.8, 1H), 3.91 (ddd, 3.1, 6.1, 9.8, 1H), 3.81 (t, 3.5,
1H), 3.64–3.45 (m, 3H), 3.42 (s, 3H), 3.39–3.30 (m, 2H); dC
(DMSO-d6) 157.3, 141.3, 125.5, 124.2, 122.8, 115.8, 95.7, 77.3,
73.3, 68.5, 68.5, 60.0, 58.4; HRMS, ESI-TOF+ m/z calcd. for C13H16
-
4.5.9. General procedure for deacetylation reactions
ClNNaO8 [M+Na]+: 372.0462; found 372.0456.
Typically, the peracetylated aryl glycopyranosides 12 were sus-
pended in 12–15 mL 7 M ammonia in methanol and stirred at
ambient temperature. After 5–24 h, all volatile material was evap-
orated. The resulting residue was recrystallized from ethyl acetate
or purified by column chromatography on silica gel as noted yield-
ing the target compounds [26].
4.5.16. 2-Chloro-4-nitrophenyl 2-O-methyl-b-
(11h)
Chromatographic purification over silica gel (hexane/ethyl acet-
ate 4/1–0/1, v/v), colorless solid; 0.77 g (2.200 mmol, 87%); Rf 0.17
(SiO2, ethyl acetate); mp 193–195 °C; dH (DMSO-d6) 8.36 (d, 2.8,
D-galactopyranoside